Innovation in research on micro- and nanoplastics and their effects on human health
We are a multidisciplinary team with expertise in a wide range of fields including food sciences & technology, allergy, immunology, biomedicine, biology, chemistry, bioinformatics, machine learning, paediatrics and others, cooperating across Europe to investigate the relationship among micro- and nanoplastics (MNPs) and allergic diseases.
The Project
Untangling the multifaceted relationship of exposure routes, risks and health impacts of MNPs.
Improving MNP detection
We plan to develop innovative tools to measure and characterize MNPs and potential contaminants in food, water and air.
MNPs combined with pollutants
We are committed to understanding the effect of MNPs combined with potentially harmful environmental contaminants adhering to their surfaces and finding their way into the human body.
The relationship with allergic diseases
We aim to examine a possible link between MNPs and their role in food allergy and allergic asthma.
Highlights
A New Protocol to Trace Microplastics in Complex Human Matrices
Imptox scientists developed a fast and highly efficient method to isolate microplastics from human stool samples, opening new possibilities for large-scale biomonitoring and exposure research.
Microplastics alter the body’s response to allergens
A new study led by Imptox partner, the Medical University of Vienna shows that PET microplastics can remain in the lungs and alter immune responses linked to allergies in mouse models, highlighting potential health implications of microplastic exposure.
Join the CUSP Roadmap Webinar on October 31st
CUSP is holding a webinar to launch the upcoming CUSP Research Roadmap on October 31st, 12 pm CET.
What Happens When Microplastics Meet Our Gut Enzymes?
A new study by Imptox researchers reveals how everyday microplastics can hitch a ride into our digestive system, interact with gastrointestinal enzymes and food proteins, and subtly interfere with how our body breaks down food.
The Imptox Team
Imptox is a multidisciplinary consortium of 12 partners from 8 European countries.
